Improved production of mycophenolic acid in Penicillium brevicompactum by RNAi-mediated hmgcl gene silencing
Fungal Biology · 2025
DOI: 10.1016/j.funbio.2025.101666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fungal Biology, 2025. Verfasst von Yi Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai, 20023…. Hauptthemen laut MEDLINE: Mycophenolic Acid, Penicillium, RNA Interference, Gene Silencing. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Shanghai Institute of Technology, Beijing Natural Science Foundation, Shanghai Municipal Natural Science Foundation.
Abstract (Originalsprache)
Penicillium brevicompactum is an industrial fungus used to produce mycophenolic acid (MPA), which has a strong Mevalonate (MVA) pathway metabolic flux. However, there are currently limited genetic manipulation tools available and few reports on metabolic regulation analysis for P. brevicompactum. In the synthesis of MPA, the MVA pathway is an important metabolic pathway, and it bifurcates at HMG-CoA, a critical node directing metabolic flux toward either MPA biosynthesis via HMG-CoA reductase or a bypass route mediated by HMG-CoA lyase (HMGCL). While metabolic engineering strategies for enhancing MPA have focused on upregulating the MVA pathway, suppression of competing HMG-CoA lyase-driven carbon diversion remains underexplored. Here, we employ RNA interference (RNAi) to silence hmgcl in P. brevicompactum, redirecting flux toward farnesyl pyrophosphate (FPP), the MPA precursor. Plasmid-based RNAi knockdown reduced hmgcl transcript levels to 6.3 % of wild-type, yielding a 59 % increase in MPA titer (4.36 g/L). Our findings establish RNAi-mediated pathway balancing as a potent strategy for optimizing isoprenoid biosynthesis and underscore the untapped potential of silencing competing enzymes in fungal secondary metabolism. This approach provides a scalable framework for enhancing high-value metabolites in non-model filamentous fungi.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai, 200237, People's Republic of China.
- School of Chemical and Environmental Engineering, Shanghai Institute of Technology, Shanghai 201418, People's Republic of China; Research Laboratory for Functional Nanomaterial, National Engineering Research Center for…
- Otorhinolaryngology, Peking University Third Hospital, Beijing, 102199, People's Republic of China.
- State Key Laboratory of Bioreactor Engineering, Newworld Institute of Biotechnology, East China University of Science and Technology, Shanghai, 200237, People's Republic of China. Electronic address: weiwei@ecust.edu.cn.
Förderung
- Shanghai Institute of Technology
- Beijing Natural Science Foundation
- Shanghai Municipal Natural Science Foundation
Zitieren
APA
Lin, Y., Wang, J., Lin, L., Li, T., Yan, Y., Wei, W., & Wei, D. (2025). Improved production of mycophenolic acid in Penicillium brevicompactum by RNAi-mediated hmgcl gene silencing. Fungal Biology. https://doi.org/10.1016/j.funbio.2025.101666
Vancouver
Lin Y, Wang J, Lin L, Li T, Yan Y, Wei W, et al. Improved production of mycophenolic acid in Penicillium brevicompactum by RNAi-mediated hmgcl gene silencing. Fungal Biology. 2025. doi:10.1016/j.funbio.2025.101666
BibTeX
@article{Lin2025,
author = {Lin, Yi and Wang, JingJing and Lin, Lin and Li, Tao and Yan, Yan and Wei, Wei and Wei, Dongzhi},
title = {Improved production of mycophenolic acid in Penicillium brevicompactum by RNAi-mediated hmgcl gene silencing},
journal = {Fungal Biology},
year = {2025},
doi = {10.1016/j.funbio.2025.101666}
}
EUVIMED